ACP-5862

Modify Date: 2025-08-25 11:20:45

ACP-5862 Structure
ACP-5862 structure
Common Name ACP-5862
CAS Number 2230757-47-6 Molecular Weight 481.51
Density N/A Boiling Point N/A
Molecular Formula C26H23N7O3 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of ACP-5862


ACP-5862 is a major active, circulating, pyrrolidine ring-opened metabolite of Acalabrutinib with an IC50 of 5.0 nM for Bruton tyrosine kinase (BTK)[1]. Acalabrutinib is an orally active, irreversible, and highly selective BTK inhibitor, with an IC50 of 3 nM and EC50 of 8 nM[2].

 Names

Name ACP-5862

 ACP-5862 Biological Activity

Description ACP-5862 is a major active, circulating, pyrrolidine ring-opened metabolite of Acalabrutinib with an IC50 of 5.0 nM for Bruton tyrosine kinase (BTK)[1]. Acalabrutinib is an orally active, irreversible, and highly selective BTK inhibitor, with an IC50 of 3 nM and EC50 of 8 nM[2].
Related Catalog
Target

IC50: 5.0 nM (BTK)[1]

References

[1]. Podoll T, et al. Bioavailability, Biotransformation, and Excretion of the Covalent Bruton Tyrosine Kinase Inhibitor Acalabrutinib in Rats, Dogs, and Humans. Drug Metab Dispos. 2019 Feb;47(2):145-154.

[2]. Herman SE, et al. The Bruton's tyrosine kinase (BTK) inhibitor acalabrutinib demonstrates potent on-target effects and efficacy in two mouse models of chronic lymphocytic leukemia. Clin Cancer Res. 2016 Nov 30

 Chemical & Physical Properties

Molecular Formula C26H23N7O3
Molecular Weight 481.51
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.